SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
PSDV - pSivida Limited
An SI Board Since November 2005
Posts SubjectMarks Bans Symbol
421 8 0 PSDV
Emcee:  John McCarthy Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
46Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina (FAVOR)John McCarthy18/20/2009
45We shall see .... -g- fwiw: - my *new* investment policy IS: spend it / lose John McCarthy18/20/2009
44If the Phase II and interim reports have validity.......I like the chances for rArthur Radley-8/20/2009
43TD This is strictly a CRAP shoot. -g- No doubt. But I like the rush. regards John McCarthy18/20/2009
42John, You sure have been busy.......thanks for sharing all the info on PSDV. HowArthur Radley-8/20/2009
41pSiVida to present at Rodman & Renshaw Annual Global Investment Conference John McCarthy18/20/2009
40Alimera Sciences Inc. Begins Pilot Study to Assess Safety and Efficacy of IluJohn McCarthy-8/20/2009
39PubMed Iluvien: a new sustained delivery technology for posterior eye disease.KJohn McCarthy-8/20/2009
38InvestorHub siliconinvestor.com StickHideOut stockhideout.com StockTwits stJohn McCarthy-8/20/2009
37WSJ 1 for 40 reverse Last Stock Split sec.online.wsj.comJohn McCarthy-8/20/2009
3612/2008 - New Evaluation for Cardiovascular Drug Delivery SEVERE EDIT Drug deJohn McCarthy-8/20/2009
35Website psivida.comJohn McCarthy-8/20/2009
34Cash Burn pSivida Corp. Reports Results for the Quarter ended March 31, 2009 John McCarthy-8/20/2009
33FWIW The short name of the trial is called FAME. (Fluocinolone Acetonide in DMEJohn McCarthy-8/19/2009
32IIuvien Cheat Sheet (taken from their August 2009 prentation as posted by TexasJohn McCarthy-8/19/2009
31Hi TD Jumped in yesterday for 3,000 shares (around $2.23) shares and will goto John McCarthy-8/19/2009
30This goes down in the FWIW category.......I made contact with the optomology depArthur Radley-8/19/2009
29Stock is swimming against the tide this morning......no volume but up by 10%....Arthur Radley-8/19/2009
28TD Thanks for posting that. JohnJohn McCarthy-8/17/2009
27phx.corporate-ir.net CEO Presentation August, 2009Arthur Radley-8/17/2009
26Journal of Ocular Pharmacology and Therapeutics Fluocinolone Inhibits VEGF ExpreArthur Radley-8/11/2009
25TD I don't follow it anymore.John McCarthy18/7/2009
24iovs.org PSDV seems to finally be coming to life......with data coming in OctobArthur Radley-8/7/2009
23New to the board Hi folks, this seems to be a quiet board for the most part. I psdvbroke-1/19/2006
22Mersana Therapeutics completes $21 million financing CAMBRIDGE, Mass. /PRNewswJohn McCarthy-11/9/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News